Wahoo FG 00074Recalls & reported problems
Q'Apel Medical LLC · SelectFlex 072 Neurovascular Access System, 105cm · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00857545008004), received between May 2, 2025 and May 2, 2025 — classified as 1 malfunction.
The most frequently reported specific device problem is “Obstruction of Flow” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Obstruction of Flow1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 2, 2025Obstruction of Flow; Obstruction of Flow
DURING A RETROSPECTIVE LEGACY COMPLAINT FILE REVIEW FOR POTENTIAL MDR REPORTABLE EVENTS, (B)(4) (EVENT DATE-01/13/2021), WAS OBSERVED TO HAVE MET THE REPORTABILITY CRITERIA AFTER THE INVESTIGATION OF THE RETURNED PRODUCT WAS COMPLETED ((B)(6) 2021). NOTE: ON (B)(6) 2023, Q'APEL MEDICAL INC. DECIDED TO CEASE THE PRODUCTION OF WAHOO SELECTFLEX 072 NEUROVASCULAR ACCESS SYSTEM. TIMELINE OF EVENTS: -(B)(4) INITIAL MDR EVALUATION: AT THE TIME OF THE COMPLAINT, Q'APEL MEDICAL DETERMINED THE EVENT WAS NOT REPORTABLE UNDER 21 CFR 803.50 BASED ON AVAILABLE INFORMATION. SPECIFICALLY, THE EVALUATION CONCLUDED THE DEVICE DID NOT: 1. CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY; OR 2. MALFUNCTION IN A WAY THAT, IF IT WERE TO RECUR, WOULD LIKELY RESULT IN A DEATH OR SERIOUS INJURY. -CASE OVERVIEW (PROVIDED BY SALES REPRESENTATIVE): 1. WAHOO CATHETER WAS TRACKED TO THE TARGET ANATOMY AND USED TO DEPLOY A SURPASS FLOW DIVERTER. 2. UPON ATTEMPT TO PASS A WIRE POST-DEPLOYMENT, RESISTANCE WAS NOTED. 3. RESISTANCE DURING WITHDRAWAL PROMPTED SIMULTANEOUS REMOVAL OF THE WAHOO AND 8F SHEATH. 4. INITIAL INSPECTION SUGGESTED THE CATHETER WAS INTACT. 5. THE PATIENT HAD HIGHLY TORTUOUS VASCULATURE. NO HAR
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21952073 ↗
Other Catheter, Percutaneous devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page